Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Antiretroviral Therapy Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Nucleoside Reverse Transcriptase Inhibitors , Non-Nucleoside Reverse Transcriptase Inhibitors , Protease Inhibitors , Integrase Strand Transfer Inhibitors , Entry and Fusion Inhibitors, Pharmacokinetic Enhancers , Combination Class Drugs ), By Route of Administration (Oral , Parenteral ), By End User (Hospitals and Clinics, Homecare Settings, Specialty Healthcare Centers) Companies, and Country Forecast, 2021 to 2034

Global Antiretroviral Therapy Market size is forecast to increase from $23.06 Billion in 2026 to $32.54 Billion in 2034 at a CAGR of 4.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005677
Pages: 227 Pages

Anti-retroviral Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Multi-Class Combination Products , Integrase Strand Transfer Inhibitors , Nucleoside / Nucleotide Reverse Transcriptase Inhibitors , Non-Nucleoside Reverse Transcriptase Inhibitors , Protease Inhibitors ), By Therapeutic Application (HIV-1 Infection Treatment, HIV-2 Infection Treatment, Pre-Exposure Prophylaxis , Post-Exposure Prophylaxis ), By Route of Administration & Regimen (Daily Oral Regimens , Long-Acting Injectable Regimens), By Patient Demographics (Adult & Geriatric Populations, Pediatric & Infant Populations), By Distribution Channel (Hospital Pharmacies, Specialized Clinics & Government Tender Pharmacies, Retail Pharmacies & Community Drugstores, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Anti-retroviral Drugs Market size is forecast to increase from $36.1 Billion in 2026 to $50.95 Billion in 2034 at a CAGR of 4.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005676
Pages: 229 Pages

Antipsychotic Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Therapeutic Class (First-Generation Antipsychotics , Second-Generation Antipsychotics , Third-Generation Antipsychotics ), By Target Indication (Schizophrenia, Bipolar Disorder, Major Depressive Disorder , Dementia-Related Psychosis, Autism Spectrum Disorders ), By Dosage Form (Oral Medications , Injectable Formulations ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drugstores, Online / E-Pharmacies, Institutional & Mental Health Center Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Antipsychotic Drugs Market size is forecast to increase from $20.41 Billion in 2026 to $33.53 Billion in 2034 at a CAGR of 6.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005675
Pages: 227 Pages

Anti-Pollution Nasal Spray Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Barrier Protection / Film-Forming Nasal Sprays, Saline-Based Nasal Sprays, Homeopathic / Herbal Nasal Sprays, Steroid & Decongestant Nasal Sprays), By Drug (Over-the-Counter , Prescription-Based Nasal Sprays), By Intended Application (Airborne Allergen & Pollutant Protection, Sinus & Nasal Congestion Relief, Asthma & Respiratory Support), By Patient Age Group (Adult Users, Pediatric Users), By Distribution Channel (Retail Pharmacies & Drugstores, Online / E-Commerce Channels, Hospital Pharmacies, Supermarkets & General Retail Outlets) Companies, and Country Forecast, 2021 to 2034

Global Anti-Pollution Nasal Spray Market size is forecast to increase from $9.39 Billion in 2026 to $15.78 Billion in 2034 at a CAGR of 6.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005674
Pages: 219 Pages

Antiplatelet Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Adenosine Diphosphate , Irreversible Cyclooxygenase , Glycoprotein , Phosphodiesterase , Protease-Activated Receptor-1 ), By Application (Myocardial Infarction , Percutaneous Coronary Interventions , Arterial Thrombosis and Acute Coronary Syndrome , Stroke Prevention and Cerebrovascular Diseases), By Mode of Administration (Oral Administration, Intravenous ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online) Companies, and Country Forecast, 2021 to 2034

Global Antiplatelet Market size is forecast to increase from $4.5 Billion in 2026 to $6.23 Billion in 2034 at a CAGR of 4.16% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005673
Pages: 225 Pages

Antiparasitic Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Anthelmintics , Antiprotozoal Agents , Ectoparasiticides ), By Application Sector (Human Health , Animal Health , Crop Health ), By Route of Administration (Oral, Injectable, Topical and Implants), By End-User (Hospitals and Specialized Clinics, Animal Farms and Production Units, Home Care) Companies, and Country Forecast, 2021 to 2034

Global Antiparasitic Drugs Market size is forecast to increase from $20.41 Billion in 2026 to $30.85 Billion in 2034 at a CAGR of 5.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005672
Pages: 212 Pages

Anti-Osteoporosis Therapy and Fracture Healing Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Bisphosphonates, Monoclonal Antibodies , Anabolic Agents , Hormone Replacement Therapy , Calcitonin and Other Mineral Supplements), By Route of Administration (Oral Formulations, Injectable ), By Application (Postmenopausal Osteoporosis, Senile and Glucocorticoid-Induced Osteoporosis, Acute Trauma , Metabolic Bone Disorders & Oncology-Related Bone Loss), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Drugstores, Online) Companies, and Country Forecast, 2021 to 2034

Global Anti-Osteoporosis Therapy and Fracture Healing Market size is forecast to increase from $17.33 Billion in 2026 to $28.47 Billion in 2034 at a CAGR of 6.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005671
Pages: 224 Pages

Anti-obesity Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Incretin Mimetics , Peripherally Acting Lipase Inhibitors, Centrally Acting Sympathomimetics, Combination Therapies), By Drug Type (Prescription Drugs, Over-the-Counter ), By Route of Administration (Oral, Parenteral ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies & Telehealth Platforms, Weight-Loss Clinics) Companies, and Country Forecast, 2021 to 2034

Global Anti-obesity Drugs Market size is forecast to increase from $8.47 Billion in 2026 to $44.66 Billion in 2034 at a CAGR of 23.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005670
Pages: 219 Pages

Antinuclear Antibody (ANA) Test Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Reagents & Assay Kits, Systems & Analyzers, Software & Services), By Technique (Immunofluorescence Assay , Enzyme-Linked Immunosorbent Assay , Multiplex Assay), By Application (Rheumatoid Arthritis, Systemic Lupus Erythematosus , Sjögren’s Syndrome, Scleroderma, Others), By End User (Hospitals, Diagnostic Laboratories, Physician Office Laboratories , Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Antinuclear Antibody (ANA) Test Market size is forecast to increase from $2.1 Billion in 2026 to $5.66 Billion in 2034 at a CAGR of 13.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005669
Pages: 215 Pages

Antimicrobial Wound Cleanser Market Size, Share and Growth Outlook, 2026: Analysis By Product Form (Solutions, Sprays, Foams, Wipes, Gels), By Ingredient Type (Antiseptics, Antibiotics, Wetting Agents & Surfactants, Natural/Biological Agents), By Wound Type (Acute Wounds , Chronic Wounds ), By End User (Hospitals & Clinics, Ambulatory Surgical Centers , Home Care Settings, Long-term Care Facilities) Companies, and Country Forecast, 2021 to 2034

Global Antimicrobial Wound Cleanser Market size is forecast to increase from $744.06 Million in 2026 to $1072.8 Million in 2034 at a CAGR of 4.68% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005668
Pages: 224 Pages